-
公开(公告)号：US07906657B2
公开(公告)日：2011-03-15
申请号：US12301067
申请日：2007-04-20
IPC分类号： C07D261/06 , C07D231/12 , C07D401/10 , C07D403/10 , A61K31/501 , A61K31/497 , A61K31/454 , A61K31/4427 , A61K31/415
CPC分类号： C07D231/12 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12
摘要： Novel 1,5-diphenylpyrazole derivatives of the formula (I) in which R1-R6 have the meanings indicated in claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
摘要翻译： 式（I）的新的1,5-二苯基吡唑衍生物，其中R 1 -R 6具有权利要求1所述的含义，是HSP90抑制剂，可用于制备用于治疗其中抑制，调节 和/或调节HSP90起作用。
-
公开(公告)号：US08791129B2
公开(公告)日：2014-07-29
申请号：US13819109
申请日：2011-08-31
IPC分类号： A01N43/54 , A61K31/517 , C07D239/72 , C07D401/00
CPC分类号： A61K31/517 , A61K31/675 , A61K45/06 , C07D401/14 , C07D403/06 , C07D403/14 , C07D405/14 , C07F9/65583
摘要： Novel quinazolinamide derivatives of the formula (I), in which R1-R43 and X have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
摘要翻译： 式（I）的新颖的喹唑啉酰胺衍生物，其中R1-R43和X具有权利要求1所述的含义，是HSP90抑制剂，可用于制备用于治疗其中抑制，调节和 /或HSP90调节起作用。
-
公开(公告)号：US20130178443A1
公开(公告)日：2013-07-11
申请号：US13819109
申请日：2011-08-31
IPC分类号： A61K31/517 , C07D401/14 , A61K45/06 , C07D405/14 , C07F9/6558 , A61K31/675 , C07D403/06 , C07D403/14
CPC分类号： A61K31/517 , A61K31/675 , A61K45/06 , C07D401/14 , C07D403/06 , C07D403/14 , C07D405/14 , C07F9/65583
摘要： Novel quinazolinamide derivatives of the formula (I), in which R1-R43 and X have the meanings indicated in claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
摘要翻译： 式（I）的新型喹唑啉酰胺衍生物，其中R1-R43和X具有权利要求1所述的含义，是HSP90抑制剂，可用于制备用于治疗其中抑制，调节和 /或HSP90调节起作用。
-
公开(公告)号：US08501754B2
公开(公告)日：2013-08-06
申请号：US12668864
申请日：2008-06-16
IPC分类号： A01N43/54 , A61K31/517 , C07D401/00
CPC分类号： C07D239/84 , C07D401/14 , C07D403/06 , C07D403/14 , C07D405/14 , C07D417/14
摘要： Novel quinazolinamide derivatives of the formula (I), in which R1-R3 have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
摘要翻译： 式（I）的新颖的喹唑啉酰胺衍生物，其中R1-R3具有权利要求1所示的含义，是HSP90抑制剂，可用于制备用于治疗其中抑制，调节和/或 HSP90的调节发挥作用。
-
公开(公告)号：US08546565B2
公开(公告)日：2013-10-01
申请号：US13133495
申请日：2009-11-12
IPC分类号： C07D239/70 , A01N43/54
CPC分类号： C07D403/12 , C07D403/06 , C07D403/14
摘要： Novel quinazolinamide derivatives of the formula (I), in which R1-R5 and X have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
摘要翻译： 式（I）的新型喹唑啉酰胺衍生物，其中R1-R5和X具有权利要求1所述的含义，是HSP90抑制剂，可用于制备用于治疗其中抑制，调节和 /或HSP90调节起作用。
-
公开(公告)号：US08119795B2
公开(公告)日：2012-02-21
申请号：US12301140
申请日：2007-04-20
IPC分类号： A61K31/4196 , C07D503/12 , C07D249/12 , C07D401/12
CPC分类号： C07D249/08 , C07D401/12 , C07D403/12
摘要： Novel triazole derivatives of the formula (I) in which R1-R6 and Y have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
摘要翻译： 式（I）的新型三唑衍生物，其中R 1 -R 6和Y具有权利要求1所述的含义，是HSP90抑制剂，可用于制备用于治疗其中抑制，调节和/ 或调制HSP90起作用。
-
公开(公告)号：US20110028485A1
公开(公告)日：2011-02-03
申请号：US12883428
申请日：2010-09-16
IPC分类号： A61K31/415 , C07D231/12 , C07D403/12 , C07D401/12 , C07D405/12 , C07D413/12 , A61K31/496 , A61K31/4439 , A61K31/422 , A61K31/501 , A61K31/497 , A61P35/00 , A61P35/04 , A61P37/00 , A61P31/00 , A61P9/10 , A61P31/12 , A61P3/10 , A61P11/06 , A61P17/06 , A61P25/00 , A61P1/00
CPC分类号： C07D231/12 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12
摘要： Novel 1,5-diphenylpyrazole derivatives of the formula (I) in which R1-R6 have the meanings indicated in claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
摘要翻译： 式（I）的新的1,5-二苯基吡唑衍生物，其中R 1 -R 6具有权利要求1所述的含义，是HSP90抑制剂，可用于制备用于治疗其中抑制，调节 和/或调节HSP90起作用。
-
公开(公告)号：US20090325974A1
公开(公告)日：2009-12-31
申请号：US12301067
申请日：2007-04-20
IPC分类号： A61K31/501 , C07D231/12 , A61K31/415 , A61K31/496 , C07D403/12 , A61P35/00
CPC分类号： C07D231/12 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12
摘要： Novel 1,5-diphenylpyrazole derivatives of the formula (I) in which R1-R6 have the meanings indicated in claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
摘要翻译： 式（I）的新的1,5-二苯基吡唑衍生物，其中R 1 -R 6具有权利要求1所示的含义，是HSP90抑制剂，可用于制备用于治疗其抑制，调节 和/或调节HSP90起作用。
-
公开(公告)号：US08722903B2
公开(公告)日：2014-05-13
申请号：US12307030
申请日：2007-06-18
IPC分类号： C07D231/56 , A61K31/44
CPC分类号： C07D403/12 , C07D231/56 , C07D405/12
摘要： Novel indazole derivatives of the formula (I), in which R1-R3 have the meanings indicated in Claim (1), are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
摘要翻译： 式（I）的新型吲唑衍生物，其中R1-R3具有权利要求（1）所示的含义，是HSP90抑制剂，可用于制备用于治疗其中抑制，调节和 /或HSP90调节起作用。
-
公开(公告)号：US20110245225A1
公开(公告)日：2011-10-06
申请号：US13133495
申请日：2009-11-12
IPC分类号： A61K31/517 , C07D403/06 , C07D401/14 , C07D403/14 , A61P35/00 , A61P31/12 , A61P37/06 , A61P29/00 , A61P11/00 , A61P31/00 , A61P9/10 , A61P19/00 , A61P25/00 , A61P35/04 , A61P35/02 , A61P31/14 , A61P31/22 , A61P31/16 , A61P31/20 , A61P31/18 , A61P3/10 , A61P17/06 , A61P1/00 , A61P27/02 , A61P1/16 , A61P25/28
CPC分类号： C07D403/12 , C07D403/06 , C07D403/14
摘要： Novel quinazolinamide derivatives of the formula (I), in which R1-R5 and X have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
摘要翻译： 式（I）的新型喹唑啉酰胺衍生物，其中R1-R5和X具有权利要求1所述的含义，是HSP90抑制剂，可用于制备用于治疗其中抑制，调节和 /或HSP90调节起作用。
-
-
-
-
-
-
-
-
-
搜索结果
64 条记录 (耗时 0.024 秒)
